⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 10, 2016Alzheimer s Research & TherapyOpen Access

Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review

S. A. S. A. Bemelmans Krista Tromp Eline M. Bunnik Richard Milne Shirlene Badger Carol Brayne Maartje Schermer Edo Richard

View Full Paper

Ask AI

Bookmark

Share

Abstract

PROSPERO international prospective register for systematic reviews CRD42016035388 . Registered 19 February 2016.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bemelmans et al. (2016) studied this question.

synapsesocial.com/papers/69d70c925413bc3de5ab34b4 https://doi.org/10.1186/s13195-016-0212-z

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Risk Factors and Preventive Interventions for Alzheimer DiseaseCohort Study · 2011 · 252 citations
2Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseCross-Sectional Study · 2012 · 3,808 citations
3Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReview · 2011 · 7,140 citations
4The A4 Study: Stopping AD Before Symptoms Begin?Original Research · 2014 · 764 citations
5Illness Representations Among First-Degree Relatives of People With Alzheimer DiseaseOriginal Research · 2000 · 147 citations

More related papers

Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease2009
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease1997
Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?2013

More from Alzheimer s Research & Therapy

Neuropsychiatric symptom networks in early- and late-onset Alzheimer's diseaseFri,
A prospective observational study measuring the stability of plasma pTau181 using the Elecsys Phospho-Tau (181P) plasma immunoassay for early detection of Alzheimer’s diseaseSat,